Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amcor plc is a global leader in the development and production of responsible packaging solutions for food, beverage, pharmaceutical, medical-device, home and personal-care products. The company operates over 200 sites in more than 40 countries with approximately $13.6 billion in annual revenue as of fiscal year ending June 2024[8][5]. It has a long history dating back to the mid-nineteenth century and has grown through significant mergers and acquisitions including its transformation into Amcor plc after acquiring Bemis Company Inc. in 2019[5][8].
Amcor’s focus includes flexible packaging, rigid containers, specialty cartons, closures and related services for various industries such as food & beverage and healthcare[4][8].
The company recently merged with Berry Global Group Inc. in May 2025[4].
Amcor emphasizes sustainability with goals like making all its packaging recyclable or reusable by the end of the decade[5].
No clinical results are relevant since it does not operate in life sciences R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amcor.